Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer

Published:2024-02 Issue: Volume:181 Page:33-39
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kim Ji Hyun,Kim Se Ik,Park Eun Young,Kim Eun Taeg,Kim Hyesu,Kim Sangeon,Park Sang-Yoon,Lim Myong Cheol

Funder

Korea Health Industry Development Institute

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference24 articles.

1. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea central Cancer registry;Ha;Obstet. Gynecol. Sci.,2021

3. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Ledermann;Ann. Oncol.,2018

4. Clinical research in ovarian cancer: consensus recommendations from the gynecologic Cancer InterGroup;Vergote;Lancet Oncol.,2022

5. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors;Cancers;2024-06-26

2. Olaparib vs. Niraparib bei fortgeschrittenem Ovarialkarzinom;TumorDiagnostik & Therapie;2024-05-28

3. Olaparib vs. Niraparib bei fortgeschrittenem Ovarialkarzinom;Geburtshilfe und Frauenheilkunde;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3